LMDX(Delisted)
LumiraDxยทNASDAQ
--
--(--)
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About LMDX
Lumiradx Limited
A next-generation POC diagnostic company addressing the current limitations of legacy POC systems
PO Box 1350, Windward 3, Regatta Office Park, Grand Cayman KY1-1108, Cayman Islands
--
LumiraDx Limited was established on August 24, 2016. They are new POC diagnostic companies that address the current limitations of older POC systems by bringing laboratory-comparable performance to POC in minutes on a single instrument with low cost of ownership. They focus on transforming community-based healthcare by providing critical diagnostic information to healthcare when needed, enabling people to make more informed medical decisions that improve health outcomes while reducing costs. They developed and launched their platform, which is an integrated system consisting of small multifunctional instruments, accurate, low-cost microfluidic test strips, and seamless, secure digital connections.
Company Financials
EPS
LMDX has released its 2023 Q2 earnings. EPS was reported at -0.16, versus the expected -0.14, missing expectations. The chart below visualizes how LMDX has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
LMDX has released its 2023 Q2 earnings report, with revenue of 21.00M, reflecting a YoY change of -53.04%, and net profit of -49.68M, showing a YoY change of 66.30%. The Sankey diagram below clearly presents LMDX's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
